CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
P3-069: IFCT0401 trial: Phase II study of gefitinib administered as first-line treatment in non-resectable adenocarcinoma with bronchioloalveolar carcinoma features (ADC-BAC) - Does disease control on gefitinib affect progression free survival and overall survival in ADC-BAC?
Author
Brechot Jeanne-Marie
Cadranel Jacques
+7Â more
Debove Pascal
Milleron Bernard
Morin Franck
Morot-Sibilot Denis
Quoix Elisabeth
Soria Jean-Charles
Souquet Pierre-Jean
Publication venue
International Association for the Study of Lung Cancer. Published by Elsevier Inc.
Publication date
31/08/2007
Field of study
Get PDF
Elsevier - Publisher Connector
P3-071: Respiratory symptoms improvement in non-resectable adenocarcinoma with bronchioloalveolar carcinoma features (ADC-BAC) treated with gefitinib: Quality of Life analysis of the IFCT-0401 trial
Author
Denis Moro-Sibilot
Franck Morin
+7Â more
Jacques Cadranel
Jean-Charles Soria
Pascal Debove
Patrick Merle
Pierre-Jean Souquet
Quan Tran
Sylvie Friard
Publication venue
'Ovid Technologies (Wolters Kluwer Health)'
Publication date
Field of study
No full text
Crossref